Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors

Monoamine oxidase inhibitors (MAOI) are a class of drugs that were originally developed for the treatment of depression but have since been expanded to be used in management of affective and neurological disorders, as well as stroke and aging-related neurocognitive changes. Ranging from irreversible...

Full description

Saved in:
Bibliographic Details
Main Authors: Amber N. Edinoff, Connor R. Swinford, Amira S. Odisho, Caroline R. Burroughs, Cain W. Stark, Walid A. Raslan, Elyse M. Cornett, Adam M. Kaye, Alan D. Kaye
Format: Article
Language:English
Published: Open Medical Publishing 2022-11-01
Series:Health Psychology Research
Online Access:https://doi.org/10.52965/001c.39576
Tags: Add Tag
No Tags, Be the first to tag this record!